Variations among 5 European countries for curative treatment of resectable oesophageal and gastric cancer: A survey from the EURECCA Upper GI Group (EUropean REgistration of Cancer CAre)

European Journal of Surgical Oncology

Volumn 42, Issue 1, 2016, Pages 116-122

  Messager, M ^a,b   De Steur, W O ^c   Van Sandick, J W ^d   Reynolds, J ^e   Pera, M ^f   Mariette, C ^b   Hardwick, R H ^g   Bastiaannet, E ^c   Boelens, P G ^c   Van Develde, C J H ^c   Allum, W H ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^e ST JAMES S HOSPITAL   (Ireland)

^f HOSPITAL DEL MAR   (Spain)

^g ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

EURECCA; Gastric cancer; International audit; Oesophageal cancer; Outcomes

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; CANCER STAGING; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; EUROPE; FEMALE; FRANCE; HUMAN; IRELAND; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PRIORITY JOURNAL; SPAIN; STOMACH ADENOCARCINOMA; STOMACH CANCER; SURGICAL MORTALITY; UNITED KINGDOM; ADENOCARCINOMA; AGED; CARCINOMA, SQUAMOUS CELL; CLINICAL TRIAL; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DISEASE FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; ESOPHAGUS RESECTION; GASTRECTOMY; GASTROESOPHAGEAL JUNCTION; GREAT BRITAIN; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PATHOLOGY; PROCEDURES; REGISTER; RISK ASSESSMENT; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CROSS-SECTIONAL STUDIES; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOGASTRIC JUNCTION; FEMALE; FRANCE; GASTRECTOMY; GREAT BRITAIN; HUMANS; IRELAND; MALE; MIDDLE AGED; NETHERLANDS; REGISTRIES; RISK ASSESSMENT; SPAIN; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 84953368243     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2015.09.017     Document Type: Article

References (9)

1. R. De Angelis, M. Sant, M.P. Coleman, et al. EUROCARE-5 Working Group Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population-based study Lancet Oncol 15 2014 23 34
2. J.L. Dikken, J.W. van Sandick, W.H. Allum, and et al. Differences in outcomes of oesophageal and gastric cancer surgery across Europe Br J Surg 100 2013 83 94
3. W. van Gijn, C.J. van de Velde Members of the EURECCA Consortium Improving quality of cancer care through surgical audit Eur J Surg Oncol 36 2010 23
4. W.O. de Steur, D. Henneman, W.H. Allum, and et al. Common data items in seven European oesophagogastric cancer surgery registries: towards a European upper GI cancer audit (EURECCA Upper GI) Eur J Surg Oncol 40 2014 325 329
5. K. Talsma, P. van Hagen, A. Brechtje, and et al. Comparison of the 6th and 7th editions of the UICC-AJCC TNM classification for esophageal cancer Ann Surg Oncol 19 2012 2142
6. L.H. Sobin, M.K. Gospodarowicz, and C. Wittekind TNM classification of malignant tumors 7th ed. 2009 Wiley-Blackwell Oxford
7. P. van Hagen, M.C. Hulshof, J.J. van Lanschot, and et al. Preoperative chemoradiotherapy for esophageal or junctional cancer N Engl J Med 366 2012 2074 2084
8. W.H. Allum, S.P. Stenning, J. Bancewicz, and et al. Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer J Clin Oncol 27 2009 5062 5067
9. J.B. Hulscher, J.W. van Sandick, A.G. de Boer, and et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus N Engl J Med 347 2002 1662 1669